Puma Biotechnology, Inc.
PBYI
$7.17
$0.091.27%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -226.19% | -30.39% | -56.47% | 229.28% | 161.77% |
| Total Depreciation and Amortization | -7.58% | 28.87% | -5.42% | -4.99% | -3.49% |
| Total Amortization of Deferred Charges | -- | -42.86% | -- | -- | -- |
| Total Other Non-Cash Items | -15.05% | 184.99% | -27.02% | -32.62% | -9.97% |
| Change in Net Operating Assets | 433.93% | -699.27% | 76.41% | 445.90% | -141.18% |
| Cash from Operations | 326.80% | -7.61% | -12.22% | 1,271.18% | -67.88% |
| Capital Expenditure | -- | 325.00% | -30.00% | 0.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 55.40% | -1,072.44% | 90.68% | -1,652.97% | 108.34% |
| Cash from Investing | 61.59% | -1,062.80% | 95.37% | -1,700.00% | 108.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -0.45% | 0.45% | 0.00% | -- |
| Cash from Financing | 0.00% | -0.01% | -1.33% | 1.15% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 205.96% | -1,321.37% | -1,097.37% | 12.85% | 21.00% |